Latest filing published 11 Sept 2026 for BIOTALYS.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Boutton Consulting: trading record in brief
All filings by Boutton Consulting on record concern Biotalys. The record holds 2 filings, all for trades on 2 September 2026.
In open-market terms, that means 1 purchase on one side and 1 sale on the other. No amount is published for 2 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 11 September 2026: an open-market sale, in Biotalys. The most recent open-market purchase was published on 10 September 2026, 59 days ago. Source: insider filings from FSMA. Past trades are no guide to future returns.
Companies and markets linked to Boutton Consulting
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 119,241 shares0Options /warrants for employees or managersOff exchangeISIN BE0974386188FSMA:biotalys-42
- 119,241 shares0Options /warrants for employees or managersOff exchangeISIN BE0974386188FSMA:biotalys-39Canonical exit: 1 Dec 2026 (T+90)
2 of 2 declarations